News

Immunodiagnostic profits rise 73.1%

14 July 2008 08:12:00

In-vitro diagnostics group Immunodiagnostic Systems saw full-year profits surge 73.1% and said that current trading is in line with expectations.

Pre-tax profit rose to £3.79m from £2.19m in 2007 on turnover that increased 88.1% to £18.66m. The acquisitions of Nordic Bioscience Diagnostics and Biocode-Hycel contributed £6.98m to revenue.

Dividend rose 20% to 1.5p per share.

"The trading in the current year is in line with management expectations and our core business continues to prosper due to the growing recognition of Vitamin D as a valuable marker of well-being," said the group.

Immunodiagnostic said the main challenge for the group in the year will be the launch of its automated analyser 3X3.

"I am satisfied that the hurdlaes in front of us as we move to the point of launch are what one would determine as normal and I am confident that our first routine sales of 3X3 to end customers will be achieved by the end of this calendar year," said chairman David Evans.

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.